← Back to list
MA06.023c, Nerve Fiber Density Testing
Effective date
Not stated in the notice
Identified
Jun 19, 2026
Summary
This is a reissue with no substantive changes to MA06.023c. The policy continues to cover skin biopsy with epidermal nerve fiber density testing for small-fiber neuropathy diagnosis under strict medical necessity criteria for Independence Blue Cross Medicare Advantage members in New Jersey. CPT codes 11102-11107 remain the applicable billing codes; older codes 11100-11101 were replaced effective 01/01/2019.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.
What to do
Action · 5 steps
01No immediate action required.
02This is an informational reissue with no policy content changes.
03Billing teams should verify that current systems are using CPT codes 11102-11107 (not deprecated codes 11100-11101) when billing nerve fiber density testing for Independence Blue Cross Medicare Advantage New Jersey members.
04Continue applying existing medical necessity criteria: patient must have painful sensory neuropathy symptoms, no predisposing disorder history, normal physical exam for large-fiber neuropathy, and normal EMG/NCS studies.
05Claims lacking these documented criteria will be denied.
Codes mentioned
111021110311104111051110611107
Original notice
MA06.023c, Nerve Fiber Density Testing
medpolicy.ibx.com · Always check the source before changing claims.